Pectus Scaffold
Chest-Wall Defects (Pectus)
Clinical TrialActive
Key Facts
About BellaSeno
BellaSeno is a clinical-stage innovator developing next-generation, fully absorbable implants for tissue reconstruction using a proprietary design and additive manufacturing platform. Its core technology leverages clinically proven polymers and complex, open-porous architectures to guide the body's natural healing without requiring biologics or stem cells. The company has active clinical programs in breast reconstruction and chest-wall defect correction and is building AI-driven, no-touch manufacturing facilities to scale production. Backed by a strong IP portfolio and an expert clinical advisory board, BellaSeno aims to set new standards in safe, effective, and personalized regenerative medicine.
View full company profile